ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO737

Development of a New Macrophage-Specific TRAP Mouse (MacTRAP) and Definition of the Renal Macrophage Translational Signature

Session Information

  • CKD: Mechanisms - III
    November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms

Authors

  • Hofmeister, Andreas, Philipps-Universität Marburg, Marburg, Germany
  • Thomassen, Maximilian Claudius, Universitätsklinikum Marburg, Marburg, Germany
  • Markert, Sabrina, Philipps Universität Marburg, Marburg, Germany
  • Marquardt, André, Universitätsklinikum Würzburg, Würzburg, Germany
  • Preußner, Mathieu, Philipps-Universität Marburg, Marburg, Germany
  • Hoyer, Joachim, Philipps Universität Marburg, Marburg, Germany
  • Humphreys, Benjamin D., Washington University School of Medicine, Clayton, Missouri, United States
  • Grgic, Ivica, Philipps-Universität Marburg, Marburg, Germany
Background

Tissue macrophages play an important role in organ homeostasis and immunity as well as pathogenesis of inflammatory-driven diseases including organ fibrosis, atherosclerosis and autoimmune disorders. One major challenge has been as how to selectively study resident macrophages in vivo in highly heterogeneous organs such as kidney.

Methods

To address this problem, we adopted a translational ribosome affinity purification (TRAP) - approach and designed a transgene that expresses an enhanced green fluorescent protein (eGFP)-tagged ribosomal protein (L10a) under the control of the macrophage-specific c-fms promoter, a driver of the macrophage colony-stimulating factor 1 receptor (Csf1r), to generate c-fms-eGFP-L10a transgenic mice (MacTRAP).

Results

Rigorous characterization and validation found no gross anatomical, behavioral or developmental abnormalities in MacTRAP mice and confirmed transgene expression across various organs. Immunohistological analyses of MacTRAP kidneys identified eGFP-L10a-expressing cells in the tubulointerstitial compartment that stained positive for macrophage marker F4/80. Following induction of kidney fibrosis we observed a robust upregulation of eGFP-L10a along with classical macrophage and fibrotic markers, validating MacTRAP responsiveness upon proinflammatory challenge. Using TRAP, we successfully extracted macrophage-specific polysomal RNA from MacTRAP kidneys and conducted RNA sequencing followed by extensive bioinformatical analyses, hereby establishing a comprehensive in vivo gene expression and pathway signature of resident renal macrophages and closely related dendritic cells.

Conclusion

In summary, we have created, validated and applied a novel and responsive macrophage-specific TRAP mouse line, defining the translational profile of renal macrophages and dendritic cells. This new and broadly applicable tool may be of great value for the study of macrophage biology in different organs and various models of injury and disease.

Funding

  • Government Support - Non-U.S.